What does CUSIP 03969K108 represent in this 13F holders report?

CUSIP 03969K108 is the security identifier for ARQT - Arcutis Biotherapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held ARQT - Arcutis Biotherapeutics, Inc. - Common Stock in Q2 2023?

135 institutional investors reported ARQT - Arcutis Biotherapeutics, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Arcutis Biotherapeutics, Inc. - Common Stock (ARQT)

CUSIP: 03969K108

Q2 2023 13F Holders as of 30 Jun 2023

Security type / class: Equity / Common Stock
Total 13F shares: 71,766,867
Total 13F value: $683,988,878
Share change: +166,027
Put/Call ratio: 53%
SEC-reported price per share: $9.53
Number of holders: 135
Value change: -$5,745,956
Number of buys: 90
Number of sells: 56
Shares outstanding: 125,896,702

Security key

03969K108

Report period

Q2 2023

Institutions

135

Top holders

ARQT full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Arcutis Biotherapeutics, Inc. SEC filings Arcutis Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 03969K108

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of ARQT - Arcutis Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ORBIMED ADVISORS LLC

Disclosed value leader

FMR LLC

Comparable rows

0/15

Latest evidence

31 Mar 2023

13F 3/4/5 Highest disclosed value: $100,786,730 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $100.79M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.

Disclosed position value Top 5

ORBIMED ADVISORS LLC $21.06M

FMR LLC $100.79M

Frazier Life Sciences Management,... $95.53M

BlackRock Finance, Inc. $50.58M

STATE STREET CORP $39.76M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ORBIMED ADVISORS LLC	13F 3/4/5 Company · 10%+ Owner 13F 3/4/5	— denominator unverified	$21,059,269 1,914,479 shares	—	31 Mar 2023
FMR LLC	13F Company 13F	— denominator unverified	$100,786,730 9,162,430 shares	—	31 Mar 2023
Frazier Life Sciences Management, L.P.	13F Company 13F	— denominator unverified	$95,526,552 8,684,232 shares	—	31 Mar 2023
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$50,580,992 4,598,272 shares	—	31 Mar 2023
STATE STREET CORP	13F Company 13F	— denominator unverified	$39,762,591 3,614,781 shares	—	31 Mar 2023
Rubric Capital Management LP	13F Company 13F	— denominator unverified	$38,500,000 3,500,000 shares	—	31 Mar 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

135

71,766,867

Rows available

135

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

141

Q2 2023 holders

135

Holder diff

-6

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q2 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend